Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018225

CFO and Country Manager acquired 77,351 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hadar Ilan · CFO and Country Manager

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-09 Grant or award : show line 1 in the form +8,339 8,339 D
2020-03-09 Grant or award : show line 2 in the form +69,012 77,351 D

Table II: Derivative

10 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 3 in the form Stock Options +3,239 $3.25 2024-03-31 3,239 3,239 D
2020-03-09 Grant or award : show line 4 in the form Stock Options +14,291 $9.22 2024-11-19 14,291 14,291 D
2020-03-09 Grant or award : show line 5 in the form Stock Options +10,663 $11.43 2025-01-15 10,663 10,663 D
2020-03-09 Grant or award : show line 6 in the form Stock Options +119,667 $12.04 2025-11-10 119,667 119,667 D
2020-03-09 Grant or award : show line 7 in the form Stock Options +35,544 $10.70 2026-03-01 35,544 35,544 D
2020-03-09 Grant or award : show line 8 in the form Stock Options +35,774 $17.40 2027-01-01 35,774 35,774 D
2020-03-09 Grant or award : show line 9 in the form Stock Options +116,231 $8.81 2027-08-08 116,231 116,231 D
2020-03-09 Grant or award : show line 10 in the form Stock Options +20,789 $10.81 2028-02-27 20,789 20,789 D
2020-03-09 Grant or award : show line 11 in the form Stock Options +56,275 $6.44 2029-01-01 56,275 56,275 D
2020-03-09 Grant or award : show line 12 in the form Stock Options +57,086 $6.81 2030-02-24 57,086 57,086 D
Loading xslF345X03/doc4.xml…